世界の子宮肉腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Uterine Sarcoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5008
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、子宮肉腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線治療、ホルモン療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・子宮肉腫治療の市場動向
・企業の競争状況、市場シェア
・子宮肉腫治療の種類別市場規模と予測2016-2027（手術、放射線治療、ホルモン療法）
・子宮肉腫治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・子宮肉腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・子宮肉腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・子宮肉腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・子宮肉腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・子宮肉腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Johnson & Johnson、General Electric、Koninklijke Philips、Siemens Healthcare、Intas Pharmaceuticals、Sun Pharmaceutical）
・結論

Sarcomas are the tumours of the mesenchymal tissues like bone, muscle, connective tissue, cartilage and fat. Uterine sarcoma is a rare type of cancer which starts in the muscle and supporting tissues of the uterus. Exposure to the X-rays increases the risk for uterine sarcoma.

Market Analysis and Insights: Global Uterine Sarcoma Treatment Market
The global Uterine Sarcoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Uterine Sarcoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Uterine Sarcoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Uterine Sarcoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Uterine Sarcoma Treatment market.

Global Uterine Sarcoma Treatment Scope and Market Size
Uterine Sarcoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Sarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Radiation Therapy
Hormone Therapy

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Johnson & Johnson
General Electric
Koninklijke Philips
Siemens Healthcare
Intas Pharmaceuticals
Sun Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Sarcoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiation Therapy
1.2.4 Hormone Therapy
1.3 Market by Application
1.3.1 Global Uterine Sarcoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Uterine Sarcoma Treatment Market Perspective (2016-2027)
2.2 Uterine Sarcoma Treatment Growth Trends by Regions
2.2.1 Uterine Sarcoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Uterine Sarcoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Uterine Sarcoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Uterine Sarcoma Treatment Industry Dynamic
2.3.1 Uterine Sarcoma Treatment Market Trends
2.3.2 Uterine Sarcoma Treatment Market Drivers
2.3.3 Uterine Sarcoma Treatment Market Challenges
2.3.4 Uterine Sarcoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Uterine Sarcoma Treatment Players by Revenue
3.1.1 Global Top Uterine Sarcoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Uterine Sarcoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Uterine Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uterine Sarcoma Treatment Revenue
3.4 Global Uterine Sarcoma Treatment Market Concentration Ratio
3.4.1 Global Uterine Sarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Sarcoma Treatment Revenue in 2020
3.5 Uterine Sarcoma Treatment Key Players Head office and Area Served
3.6 Key Players Uterine Sarcoma Treatment Product Solution and Service
3.7 Date of Enter into Uterine Sarcoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Sarcoma Treatment Breakdown Data by Type
4.1 Global Uterine Sarcoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Uterine Sarcoma Treatment Forecasted Market Size by Type (2022-2027)

5 Uterine Sarcoma Treatment Breakdown Data by Application
5.1 Global Uterine Sarcoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Uterine Sarcoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Uterine Sarcoma Treatment Market Size (2016-2027)
6.2 North America Uterine Sarcoma Treatment Market Size by Type
6.2.1 North America Uterine Sarcoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Uterine Sarcoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Uterine Sarcoma Treatment Market Size by Type (2016-2027)
6.3 North America Uterine Sarcoma Treatment Market Size by Application
6.3.1 North America Uterine Sarcoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Uterine Sarcoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Uterine Sarcoma Treatment Market Size by Application (2016-2027)
6.4 North America Uterine Sarcoma Treatment Market Size by Country
6.4.1 North America Uterine Sarcoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Uterine Sarcoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Uterine Sarcoma Treatment Market Size (2016-2027)
7.2 Europe Uterine Sarcoma Treatment Market Size by Type
7.2.1 Europe Uterine Sarcoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Uterine Sarcoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Uterine Sarcoma Treatment Market Size by Type (2016-2027)
7.3 Europe Uterine Sarcoma Treatment Market Size by Application
7.3.1 Europe Uterine Sarcoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Uterine Sarcoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Uterine Sarcoma Treatment Market Size by Application (2016-2027)
7.4 Europe Uterine Sarcoma Treatment Market Size by Country
7.4.1 Europe Uterine Sarcoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Uterine Sarcoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Uterine Sarcoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Uterine Sarcoma Treatment Market Size by Type
8.2.1 Asia-Pacific Uterine Sarcoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Uterine Sarcoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Uterine Sarcoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Uterine Sarcoma Treatment Market Size by Application
8.3.1 Asia-Pacific Uterine Sarcoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Uterine Sarcoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Uterine Sarcoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Uterine Sarcoma Treatment Market Size by Region
8.4.1 Asia-Pacific Uterine Sarcoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Uterine Sarcoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Uterine Sarcoma Treatment Market Size (2016-2027)
9.2 Latin America Uterine Sarcoma Treatment Market Size by Type
9.2.1 Latin America Uterine Sarcoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Uterine Sarcoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Uterine Sarcoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Uterine Sarcoma Treatment Market Size by Application
9.3.1 Latin America Uterine Sarcoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Uterine Sarcoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Uterine Sarcoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Uterine Sarcoma Treatment Market Size by Country
9.4.1 Latin America Uterine Sarcoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Uterine Sarcoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Uterine Sarcoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Uterine Sarcoma Treatment Market Size by Type
10.2.1 Middle East & Africa Uterine Sarcoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Uterine Sarcoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Uterine Sarcoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Uterine Sarcoma Treatment Market Size by Application
10.3.1 Middle East & Africa Uterine Sarcoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Uterine Sarcoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Uterine Sarcoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Uterine Sarcoma Treatment Market Size by Country
10.4.1 Middle East & Africa Uterine Sarcoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Uterine Sarcoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Uterine Sarcoma Treatment Introduction
11.1.4 Pfizer Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Uterine Sarcoma Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 General Electric
11.3.1 General Electric Company Details
11.3.2 General Electric Business Overview
11.3.3 General Electric Uterine Sarcoma Treatment Introduction
11.3.4 General Electric Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.3.5 General Electric Recent Development
11.4 Koninklijke Philips
11.4.1 Koninklijke Philips Company Details
11.4.2 Koninklijke Philips Business Overview
11.4.3 Koninklijke Philips Uterine Sarcoma Treatment Introduction
11.4.4 Koninklijke Philips Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.4.5 Koninklijke Philips Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Uterine Sarcoma Treatment Introduction
11.5.4 Siemens Healthcare Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.5.5 Siemens Healthcare Recent Development
11.6 Intas Pharmaceuticals
11.6.1 Intas Pharmaceuticals Company Details
11.6.2 Intas Pharmaceuticals Business Overview
11.6.3 Intas Pharmaceuticals Uterine Sarcoma Treatment Introduction
11.6.4 Intas Pharmaceuticals Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.6.5 Intas Pharmaceuticals Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Details
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Uterine Sarcoma Treatment Introduction
11.7.4 Sun Pharmaceutical Revenue in Uterine Sarcoma Treatment Business (2016-2021)
11.7.5 Sun Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Uterine Sarcoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Hormone Therapy
Table 5. Global Uterine Sarcoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Uterine Sarcoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Uterine Sarcoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Uterine Sarcoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Uterine Sarcoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Uterine Sarcoma Treatment Market Share by Regions (2022-2027)
Table 11. Uterine Sarcoma Treatment Market Trends
Table 12. Uterine Sarcoma Treatment Market Drivers
Table 13. Uterine Sarcoma Treatment Market Challenges
Table 14. Uterine Sarcoma Treatment Market Restraints
Table 15. Global Uterine Sarcoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Uterine Sarcoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Uterine Sarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Sarcoma Treatment as of 2020)
Table 18. Ranking of Global Top Uterine Sarcoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Uterine Sarcoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Uterine Sarcoma Treatment Product Solution and Service
Table 22. Date of Enter into Uterine Sarcoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Uterine Sarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Uterine Sarcoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Uterine Sarcoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Uterine Sarcoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Uterine Sarcoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Uterine Sarcoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Uterine Sarcoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Uterine Sarcoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Uterine Sarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Uterine Sarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Uterine Sarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Uterine Sarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Uterine Sarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Uterine Sarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Uterine Sarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Uterine Sarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Uterine Sarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Uterine Sarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Uterine Sarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Uterine Sarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Uterine Sarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Uterine Sarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Uterine Sarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Uterine Sarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Uterine Sarcoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Uterine Sarcoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Uterine Sarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Uterine Sarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Uterine Sarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Uterine Sarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Uterine Sarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Uterine Sarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Uterine Sarcoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Uterine Sarcoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Uterine Sarcoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Uterine Sarcoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Uterine Sarcoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Uterine Sarcoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Uterine Sarcoma Treatment Product
Table 65. Pfizer Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Uterine Sarcoma Treatment Product
Table 70. Johnson & Johnson Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. General Electric Company Details
Table 73. General Electric Business Overview
Table 74. General Electric Uterine Sarcoma Treatment Product
Table 75. General Electric Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 76. General Electric Recent Development
Table 77. Koninklijke Philips Company Details
Table 78. Koninklijke Philips Business Overview
Table 79. Koninklijke Philips Uterine Sarcoma Treatment Product
Table 80. Koninklijke Philips Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Koninklijke Philips Recent Development
Table 82. Siemens Healthcare Company Details
Table 83. Siemens Healthcare Business Overview
Table 84. Siemens Healthcare Uterine Sarcoma Treatment Product
Table 85. Siemens Healthcare Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Siemens Healthcare Recent Development
Table 87. Intas Pharmaceuticals Company Details
Table 88. Intas Pharmaceuticals Business Overview
Table 89. Intas Pharmaceuticals Uterine Sarcoma Treatment Product
Table 90. Intas Pharmaceuticals Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Intas Pharmaceuticals Recent Development
Table 92. Sun Pharmaceutical Company Details
Table 93. Sun Pharmaceutical Business Overview
Table 94. Sun Pharmaceutical Uterine Sarcoma Treatment Product
Table 95. Sun Pharmaceutical Revenue in Uterine Sarcoma Treatment Business (2016-2021) & (US$ Million)
Table 96. Sun Pharmaceutical Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Sarcoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiation Therapy Features
Figure 4. Hormone Therapy Features
Figure 5. Global Uterine Sarcoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Uterine Sarcoma Treatment Report Years Considered
Figure 10. Global Uterine Sarcoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Uterine Sarcoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Uterine Sarcoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Uterine Sarcoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Uterine Sarcoma Treatment Market Share by Players in 2020
Figure 15. Global Top Uterine Sarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Sarcoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Uterine Sarcoma Treatment Revenue in 2020
Figure 17. Global Uterine Sarcoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Uterine Sarcoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Uterine Sarcoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Uterine Sarcoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Uterine Sarcoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Uterine Sarcoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Uterine Sarcoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Uterine Sarcoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Uterine Sarcoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Uterine Sarcoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Uterine Sarcoma Treatment Market Share by Region (2016-2027)
Figure 39. China Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Uterine Sarcoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Uterine Sarcoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Uterine Sarcoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Uterine Sarcoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Uterine Sarcoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Uterine Sarcoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Uterine Sarcoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 60. General Electric Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 61. Koninklijke Philips Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 62. Siemens Healthcare Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 63. Intas Pharmaceuticals Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 64. Sun Pharmaceutical Revenue Growth Rate in Uterine Sarcoma Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年）

Global Uterine Fibroids Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5006 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、子宮筋腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（子宮内膜アブレーション、MRIガイド処理、子宮摘出術、筋腫核出術、子宮動脈塞栓術、ラジオ波焼灼術、その他）、用途別市場規模（病院、外科医院、...

世界の子宮筋腫治療装置市場規模・現状・予測（2021年-2027年）

Global Uterine Fibroid Treatment Device Market Size, Status and Forecast 2021-2027
QFJ1-5371 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、子宮筋腫治療装置の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術手技、腹腔鏡下手技、切除術、塞栓術）、用途別市場規模（侵襲的治療、最小侵襲的治療、非侵襲的治療）、主要地域別市場規模（北米、アメリカ...

世界の子宮ポリープ治療薬市場規模・現状・予測（2021年-2027年）

Global Uterine Polyps Drug Market Size, Status and Forecast 2021-2027
QFJ1-5007 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、子宮ポリープ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（病院、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のカポジ肉腫診断市場規模・現状・予測（2021年-2027年）

Global Kaposi Sarcoma Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4401 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、カポジ肉腫診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生検、イメージング）、用途別市場規模（病院、診断センター、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の子宮筋腫治療薬市場規模・現状・予測（2021年-2027年）

Global Uterine Fibroids Drug Market Size, Status and Forecast 2021-2027
QFJ1-5005 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、子宮筋腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（病院、診療所、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の子宮疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Uterine Diseases Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5004 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、子宮疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の高密度焦点式超音波（HIFU）治療市場規模・現状・予測（2021年-2027年）

Global High-intensity Focused Ultrasound (HIFU) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4313 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、高密度焦点式超音波（HIFU）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（超音波ガイド、MRガイド）、用途別市場規模（前立腺がん、子宮筋腫、神経疾患、美容、その他）、主要地域別市場規模（北米、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年） Uterine fibroids are frequently found incidentally during a routine pelvic exam. There's no single best approach to uterine fibroid treatment — many treatment options exist. Market Analysis and Insights: Global Uterine Fibroids Treatment Market The global Uterine Fibroids Treatment market size is pr…
世界の子宮筋腫治療装置市場規模・現状・予測（2021年-2027年） Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer. Market Analysis and Insights: Glo…
滑膜肉腫治療のグローバル市場調査 2019年 The global Synovial Sarcoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Synovial Sarcoma Treatment volume and value at global level, regional level and company level. From a global per…
滑膜肉腫治療のグローバル市場調査 2019年 The global Synovial Sarcoma Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Synovial Sarcoma Treatment volume and value at global level, regional level and company level. From a global per…
世界のカポジ肉腫診断市場規模・現状・予測（2021年-2027年） Kaposi sarcoma cancer is a type of soft tissue cancer. Kaposi sarcoma is a group of cancer that starts in the tissue that supports and connects the body. Kaposi sarcoma cancer generally located below the skins surface or in the lining of the nose and mouth. Kaposi sarcoma cancer is basically caused …